Emcure Pharmaceuticals Share Price
₹1,438.05 -6.3 (-0.44%)
28 Dec, 2024 00:23
Start SIP in EMCURE
Start SIPPerformance
- Low
- ₹1,415
- High
- ₹1,460
- 52 Week Low
- ₹1,225
- 52 Week High
- ₹1,580
- Open Price₹1,443
- Previous Close₹1,444
- Volume35,332
Investment Returns
- Over 1 Month + 4.65%
- Over 3 Month + 0.41%
- Over 6 Month + 42.66%
- Over 1 Year + 42.66%
Smart Investing Starts Here Start SIP with Emcure Pharmaceuticals for Steady Growth!
Emcure Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 48
- PEG Ratio
- -
- Market Cap Cr
- 27,241
- P/B Ratio
- 8.7
- Average True Range
- 43.66
- EPS
- 30.3
- Dividend Yield
- 0
- MACD Signal
- 2.42
- RSI
- 59.91
- MFI
- 59.87
Emcure Pharmaceuticals Financials
Emcure Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,438.05
-6.3
(-0.44%)
- Bullish Moving Average 13
- Bearish Moving Average 0
- 20 Day
- ₹1,392.40
- 50 Day
- ₹1,389.30
- 100 Day
- ₹1,385.76
- 200 Day
- -
Resistance and Support
1437.7
- R3 1,505.00
- R2 1,482.45
- R1 1,460.25
- S1 1,415.50
- S2 1,392.95
- S3 1,370.75
Emcure Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-07 | Quarterly Results | |
2024-08-13 | Quarterly Results |
Emcure Pharmaceuticals F&O
About Emcure Pharmaceuticals
- NSE Symbol
- EMCURE
- BSE Symbol
- 544210
- Managing Director & CEO
- Mr. Satish Ramanlal Mehta
- ISIN
- INE168P01015
Similar Stocks to Emcure Pharmaceuticals
Emcure Pharmaceuticals FAQs
Emcure Pharmaceuticals share price is ₹1,438 As on 28 December, 2024 | 00:09
The Market Cap of Emcure Pharmaceuticals is ₹27241.2 Cr As on 28 December, 2024 | 00:09
The P/E ratio of Emcure Pharmaceuticals is 48 As on 28 December, 2024 | 00:09
The PB ratio of Emcure Pharmaceuticals is 8.7 As on 28 December, 2024 | 00:09
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.